United States · Bill · S
S. 946 (108th)
Drug Competition Act of 2003
Introduced
29 April 2003
Last action
29 April 2003 · Introduced
Status
Read twice and referred to the Committee on the Judiciary.
Sponsors
Sen. Leahy, Patrick J. [D-VT], Chuck Grassley, Richard Durbin, Sen. Feingold, Russell D. [D-WI], Sen. Kohl, Herb [D-WI], Charles Schumer, Maria Cantwell
Subjects
Discovery layer
Source updated
10 August 2026
Summary
Drug Competition Act of 2003 - Sets filing requirements for a generic drug applicant that has submitted an Abbreviated New Drug Application (ANDA) and a brand name drug company that enter into an agreement, before a drug enters the market, regarding: (1) the manufacture, marketing, or sale of the brand name or the generic drug; or (2) the 180-day semi-exclusivity period referred to in the Federal Food, Drug, and Cosmetic Act as it applies to such ANDA or any other ANDA based on the same brand name drug. Requires each such party to file such agreement and any related agreements with the Assistant Attorney General and the Federal Trade Commission (FTC). Makes an exception for agreements that solely concern purchase orders for raw material supplies, equipment and facility contracts, or employment or consulting contracts. Requires such agreements to be filed not later than ten business days after the date they are executed. Exempts any such information or documentary material filed from disclosure under the Freedom of Information Act. Prohibits such information or material from being made public, except as relevant to any administrative or judicial action or proceeding. Subjects an applicant or company to a civil penalty of up to $11,000 for each day such entity fails to comply with this Act, recoverable in a civil action brought by the United States or the FTC. Authorizes a U.S. district court to order compliance and grant equitable relief.
This text is taken from the official record. PoliticalRepo does not editorialize.
Timeline
29 April 2003
Introduced
Read twice and referred to the Committee on the Judiciary.
Source: IntroReferral
29 April 2003
Introduced
Sponsor introductory remarks on measure. (CR S5493-5494)
Source: IntroReferral
29 April 2003
Introduced
Introduced in Senate
Source: IntroReferral
Votes
No vote records are attached yet.
Versions
- Introduced in Senate · 29 April 2003 · Official file
Documents
3 official files
Introduced in Senate (text)
Introduced in Senate (text)
Introduced in Senate · EN · 29 April 2003
Introduced in Senate (PDF)
Introduced in Senate · EN · 29 April 2003
Introduced in Senate
summary · EN · 29 April 2003
Sponsors
- Sen. Leahy, Patrick J. [D-VT] · D · Sponsor
- Chuck Grassley · R · Sponsor
- Richard Durbin · D · Sponsor
- Sen. Feingold, Russell D. [D-WI] · D · Sponsor
- Sen. Kohl, Herb [D-WI] · D · Sponsor
- Charles Schumer · D · Sponsor
- Maria Cantwell · D · Cosponsor
- · ssju00 · Standing
Related records
No cross-record relationships stored yet.
Sources
PoliticalRepo is an index and interpretation layer, not the authoritative legal source.
- Official source: https://www.congress.gov/bill/108th-congress/senate-bill/946
- Open data entity: https://api.congress.gov/v3/bill/108/s/946
- us · 108-s-946 · source updated 10 August 2026